Myelodysplastic/myeloproliferative Neoplasm, also known as myelodysplastic-myeloproliferative diseases, is related to acute myeloid leukaemia with myelodysplasia-related features and thrombocytosis. An important gene associated with Myelodysplastic/myeloproliferative Neoplasm is SETBP1 (SET Binding Protein 1), and among its related pathways/superpathways are Infectious disease and ERK Signaling. The drugs Mercaptopurine and Fludarabine have been mentioned in the context of this disorder. Affiliated tissues include bone marrow and myeloid, and related phenotypes are Decreased viability and Decreased substrate adherent cell growth